test

John R. Warren

@Farallon Capital Management Llc

Latest period2024 - Q3ReportedManaged Assets$20.437BTotal holdings153
Assets growth rate-3.56%Assets growth rate (2-Q avg)-3.73%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Farallon Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 153 positions.

Assets under management

The assets under management (AUM) of Farallon Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 20.437B in assets, with a quarterly growth rate of -3.56% and a 2-quarter average growth rate of -3.73%. The portfolio is managed by John R. Warren, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AZNAstrazeneca Plc
Recent Activity
Exited
0%
$187.934M
2.41M shares@ $78.0 avg price
4626⤦Iqiyi Inc
Recent Activity
Exited
0%
$162.081M
163.1M shares@ $1.0 avg price
CERECerevel Therapeutics Hldng I
Recent Activity
Exited
0%
$48.659M
1.19M shares@ $40.89 avg price
CRSPCrispr Therapeutics Ag
Recent Activity
Exited
0%
$28.625M
530,000 shares@ $54.01 avg price
SYRESpyre Therapeutics Inc
Recent Activity
Exited
0%
$15.658M
666,000 shares@ $23.51 avg price
PCGPg&e Corp
Recent Activity
Exited
0%
$12.088M
692,323 shares@ $17.47 avg price
RIORio Tinto Plc
Recent Activity
Exited
0%
$9.065M
137,500 shares@ $65.93 avg price
BACABerenson Acquisition Corp I
Recent Activity
Exited
0%
$3.043M
285,715 shares@ $10.66 avg price
ARYDArya Sciences Acqu Corp Iv
Recent Activity
Exited
0%
$2.292M
200,000 shares@ $11.46 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Exited
0%
$2.271M
108,799 shares@ $20.87 avg price